+110.7%
MCK vs EMR
+62.0%
+48.7%
-27.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.1% | +2.6% | -2.5% | +0.1% |
| 7D | -2.9% | -0.4% | -2.5% | -2.9% |
| 30D | +0.4% | -6.8% | +7.2% | +0.2% |
| 3M | +12.1% | +7.5% | +4.6% | +12.4% |
| 6M | -5.4% | +9.9% | -15.3% | -5.1% |
| YTD | +7.8% | +16.0% | -8.2% | +7.7% |
| 1Y | +22.9% | +12.4% | +10.5% | +22.9% |
| 3Y | +110.7% | +60.2% | +50.5% | +117.1% |
| All | +110.7% | +62.0% | +48.7% | +117.1% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling